News|Articles|January 5, 2026

FDA Action Update, December 2025: Acceptance, Approval, and Clearance

Catch up on any of the neurology news headlines you may have missed in December 2025, compiled into 1 place by the NeurologyLive® team.

The FDA was busy in December 2025, making a number of decisions on potential new therapeutic agents, including accepting a new drug application, clearing the initiation of a clinical trial, granting an approval, pushing back a review, and expanding an indication.